Kinetics of tumor growth and of cell proliferation in U.R.D.T. cancers: therapeutic implications.
After a brief survey of the factors of clinical tumor radioresistance the available data on the growth rate and on the kinetics of cell proliferation of U.R.D.T. tumors are reviewed.  The growth fraction and the cell turnover rate appear to be similar in U.R.D.T. tumors and in other squamous cell carcinomas.  These two parameters are correlated with clinical tumor radiosensitivity and chemosensitivity.  The possible value of tailoring fractionation and drug administration to the biological characteristics of the tumor is discussed.
D000818:Animals; D002294:Carcinoma, Squamous Cell / Q000473:pathology* / Q000532:radiotherapy; D002455:Cell Division; D004064:Digestive System / Q000473:pathology*; D006801:Humans; D007700:Kinetics; D007822:Laryngeal Neoplasms / Q000473:pathology* / Q000532:radiotherapy; D009062:Mouth Neoplasms / Q000473:pathology / Q000532:radiotherapy; D011879:Radiotherapy Dosage; D012142:Respiratory Tract Neoplasms / Q000473:pathology* / Q000532:radiotherapy; D013936:Thymidine / Q000378:metabolism
D013936:Thymidine